The Results of Pars Plana Vitrectomy in Diabetic Macular Edema

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03384901

Enrollment

Registered

2017-12-28

Start date

2018-01-31

Completion date

2019-01-31

Last updated

2017-12-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Macular Edema

Brief summary

This study will be a retrospective analysis of vitrectomy results in patients suffering from diabetic macular edema.

Interventions

PROCEDUREvitrectomy

Pars plana vitrectomy and ILM (internal limiting membrane) peeling

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Diabetic macular edema patients after vitrectomy

Exclusion criteria

* All others

Design outcomes

Primary

Measure	Time frame	Description
Visual acuity	6 months	Visual acuity will be measured using the Snellen Chart before and after vitrectomy

Secondary

Measure	Time frame	Description
Macular thickness	6 months	Macular thickness will be measured using Optical Coherence Tomography before and after vitrectomy

Countries

Israel

Contacts

Primary ContactEran Berkowitz, MD

eran.berko@gmail.com972-54-6455753

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026